2024 Latin America Virology and Bacteriology Market for over 100 Tests: A 7-Country Analysis-Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation, Opportunities

July 2020 | 975 pages | ID: 2AB3E893C32EN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report is available by section, and can be customized to specific information needs and budget.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Country Analyses

Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela

Market Segmentation Analysis

• Sales and market shares of major suppliers of infectious disease diagnostic products in major countries by test.
• Test and sales forecasts for 100 infectious disease diagnostic assays by country, individual test and market segment:
• Review of market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products

• In-depth examination of major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.
• Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

• Assessment of emerging diagnostic technologies and their potential applications for infectious disease testing.
• Companies developing or marketing infectious disease diagnostic products by individual test.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

• Emerging opportunities for new instrumentation, reagent systems, IT and other products with significant market appeal during the next five years.
• Design criteria for decentralized testing products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Contains 975 pages and 137 tables

Contents

I. INTRODUCTION

II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products

III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. OVERVIEW OF MAJOR TESTS, TECHNOLOGIES AND INSTRUMENTATION

A. Major Infectious Disease Tests
  1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
  2. Adenovirus
  3. Aeromonas
  4. Anthrax/Bacillus Anthracis
  5. Arboviruses
  6. Babesiosis
  7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
  8. Blastocystis Hominis
  9. Brucella
  10. Campylobacter
  11. Candida
  12. Carbapenemase
  13. Chagas Disease
  14. Chancroid
  15. Chlamydia
  16. Clostridium Difficile
  17. Coronaviruses
  18. Coxsackieviruses
  19. Creutzfeldt-Jakob’s Disease
  20. Cryptosporidium Parvum
  21. Cyclospora Cayetanensis
  22. Cytomegalovirus
  23. Ebola Virus
  24. E. Coli
  25. Echovirus
  26. Encephalitis
  27. Enteroviruses
  28. Epstein-Barr Virus
  30. Giardia Lamblia
  31. Gonorrhea
  32. Granuloma Inguinale
  33. Hantavirus
  34. Helicobacter Pylori
  35. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
  36. Herpes Simplex Virus
  37. Human Herpes Virus-6 (HHV-6)
  38. Influenza Viruses
  39. Legionella
  40. Lyme Disease
  41. Lymphogranuloma Venereum (LGV)
  42. Malaria
  43. Measles (Rubeola)
  44. Meningitis
  45. Microsporidium
  46. Mononucleosis
  47. Mumps
  48. Mycoplasma
  49. Norovirus
  50. Papillomaviruses
  51. Parvovirus B19
  52. Pneumonia
  53. Polyomaviruses
  54. Pseudomonas Aeruginosa
  55. Rabies
  56. Respiratory Syncytial Virus (RSV)
  57. Rhinoviruses
  58. Rotavirus
  59. Rubella
  60. Salmonellosis
  61. Septicemia
  62. Shigellosis
  63. Staphylococcus Aureus
  64. Streptococci
  65. Syphilis
  66. Toxoplasmosis
  67. Trichomonas Vaginalis
  68. Tuberculosis
  69. Vibrio
  70. West Nile Virus
  71. Yersina
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Others
D. Personal Testing

VII. COUNTRY ANALYSES: SALES AND VOLUME FORECASTS FOR 100 MICROBIOLOGY TESTS, SUPPLIER SHARES

Argentina
Brazil
Chile
Colombia
Mexico
Peru
Venezuela

VIII. COMPETITIVE ASSESSMENTS

Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Quest Diagnostics
Quidel
Roche
Scienion
Sequenom/LabCorp
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Wako Chemical

List Of Tables

LIST OF TABLES

Argentina
All Market Segments Infectious Disease Test Volume Forecast by Assay
Argentina
All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
Brazil
All Market Segments Infectious Disease Test Volume Forecast by Assay
Brazil
All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
Chile
All Market Segments Infectious Disease Test Volume Forecast by Assay
Chile
All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
Colombia
All Market Segments Infectious Disease Test Volume Forecast by Assay
Colombia
All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
Mexico
All Market Segments Infectious Disease Test Volume Forecast by Assay
Mexico
All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
Peru
All Market Segments Infectious Disease Test Volume Forecast by Assay
Peru
All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
Venezuela
All Market Segments Infectious Disease Test Volume Forecast by Assay
Venezuela
All Market Segments Infectious Disease Diagnostics Market Forecast by Assay
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Carbapenemase Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Norovirus Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests